Affiliation:
1. Raiganj University
2. Maharaja Sriram Chandra Bhanja Deo University
Abstract
Abstract
Context
The human respiratory syncytial virus (RSV) creates a pandemic every year in the European country. Lack of target therapeutics and absence of vaccines have prompted scientists to create novel vaccines or small chemical treatments against RSV's numerous targets. The matrix (M) protein and fusion (F) glycoprotein of RSV are well characterized and attractive drug targets. Five bioactive compounds from Alnus japonica (Thunb.) Steud. were taken into consideration as lead compounds. Drug-likeness characters of them showed the drugs are non-toxic and non-mutagenic and mostly lipophobic. Molecular docking reveals that all bioactive compounds have better binding and better inhibitory effect than ribavirin which is currently used against RSV. Praecoxin A appeared as the best lead compound between them. It creates 7 different types of bonds with amino acids of M protein and 5 different types of bonds with amino acids of F protein. Van der Waals interactions highly influenced the binding energies. Molecular dynamic simulations represent the non-deviated and less fluctuating nature of praecoxin A. Principal Component Analysis showed praecoxin A complex with RSV matrix protein is more stable than ribavirin complex. This study will help to develop a new drug to inhibit RSV.
Methods
All ligands were minimized through semi-empirical PM3 process with MOPAC. Toxicity was tested by ProTox-II server. Molecular docking studies were carried out using AutoDock 4.2. Molecular dynamics simulations for 100ns were carried out through GROMACS 5.12 MD and GROMOS96 43a1 force field. The graphs were produced by GROMACS's XMGrace program.
Publisher
Research Square Platform LLC
Reference76 articles.
1. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization;Chanock RO;Am J Hyg,1957
2. Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series;Scheltema NM;Lancet Glob Health,2017
3. Comparison of severe pneumonia caused by Human metapneumovirus and respiratory syncytial virus in hospitalized children;Wang Y;Indian J Pathol Microbiol,2014
4. Serological Survey of Respiratory Syncytial Virus (RSV) Among Children in Lorin North-Central, Nigeria;Kolawole MB;Pakistan J Med Dentistry,2017
5. Survey of diagnostic testing for respiratory syncytial virus (RSV) in adults: infectious disease physician practices and implications for burden estimates;Allen KE;Diagn Microbiol Infect Dis,2018